AzTrials
AzTrials

MentalisationNCT07065071

Mentalization-Based Therpay With Older Adults

An observational study of Mentalisation and Mentalization, run by University of Nottingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators would like to find out if Mentalization-Based Therapy (MBT) is effective for people aged 60+ who struggle in relationships. The study aims to understand whether MBT helps older people to build better relationships and feel better about themselves. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Mentalisation, Mentalization, Later Life
What is being tested?
Mentalization-Based Therapy
How many people
3 participants
Where
1 siteUnited Kingdom
Study dates
1 Apr 2025to 22 Jan 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Up to six participants will be recruited via purposive convenience sampling from people enrolled on one of Derbyshire Healthcare Foundation Trust's (DHCFT's) Later Life MBT interventions. The MBT group interventions take place in a secondary care outpatient setting. Once participants have been recruited, they will be asked to invite someone with whom they have a close relationship to participate in the study, known as the informant. Up to six informants will be recruited in this way via purposive convenience sampling. Up to four clinicians running the Later Life MBT intervention will be recruited via purposive convenience sampling, since they will be the people already running the group.

Who may be able to join

  • Participants - people who:
  • Have been referred into and assessed as suitable for a Derbyshire Healthcare NHS Foundation Trust's Later Life MBT Group
  • Have persistent (i.e. 1 year+) and pervasive (i.e. multiple relationships) difficulties in relationships and so stand to benefit from the intervention
  • Those aged 60+
  • Have the ability to complete measures
  • Can communicate comfortably in spoken and written English
Show all 14Show fewer
  • Informants - people who:
  • Are identified by the participant
  • Are aged 18+
  • The participant considers themselves to have a close relationship with
  • Have the ability to complete appropriate measures
  • Can communicate comfortably in spoken and written English
  • Clinicians - people who:
  • Are involved in delivering/facilitating the MBT interventions with participants

Who cannot join

  • Participants - people who:
  • Are undertaking any other psychological intervention
  • Do not have the capacity to give informed consent; since capacity is dynamic, this will be assessed by clinicians and the independent outcome assessor on an ongoing basis according to their clinical judgement. If lack of capacity is identified during an interview, clinical judgement would be used around rescheduling and the information would be fed back to the individual's clinical team or escalated as necessary
  • Informants - people who:
  • Do not have the capacity to give informed consent; since capacity is dynamic, this will be assessed by the independent outcome assessor according to their clinical judgement. If lack of capacity was identified during an interview, clinical judgement would be used around rescheduling and the information would be escalated as necessary
  • Clinicians - people who:
  • n/a

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Derbyshire Healthcare NHS Foundation Trust

    Derby, Derbyshire, DE22 3LZ

Other trials in United Kingdom

About this study

Official title: Mentalization-Based Therapy (MBT) With Older Adults: A Hermeneutic Single-Case Efficacy Design (HSCED) Series

The investigators would like to find out if Mentalization-Based Therapy (MBT) is effective for people aged 60+ who struggle in relationships. The study aims to understand whether MBT helps older people to build better relationships and feel better about themselves. There is currently no research with people over 60 and MBT, yet MBT is being offered to the older adult population by NHS trusts throughout the UK without evidence for its effectiveness. As well as developing knowledge about how MBT can help at this point in life, the study aims to improve the quality of care offered.

MBT targets mentalization, which is the ability to make sense of one's own and other people's thoughts, feelings, actions and beliefs. Current research suggests that the ability to mentalize changes over the lifespan and may be influenced by many factors, some of which are specific to later life. For example, changes in relationships during later life and biological changes in the brain may impact mentalization systems.

Read more

The investigators would also like to understand what difficulties MBT may be effective for in later life. The diagnosis of borderline personality disorder (BPD), which MBT was developed to treat, was, until recently, assumed to disappear with age. However, growing evidence suggests that symptoms change, rather than disappear.

Given these unknowns, the study will use a Hermeneutic Single-Case Efficacy Design (HSCED). Up to six participants, up to six people who know the participants, and clinicians delivering the MBT interventions will be recruited. Data in the form of questionnaires, self-report and therapy documents will be gathered, and everyone will be interviewed. For each participant, the data will be used to compile both an affirmative (yes, MBT was effective) case, and a sceptic case (no, MBT was not effective). Cases will then be reviewed by an adjudication panel comprising one service user expert by experience, one MBT expert and one expert in another therapeutic modality. For each case, each expert will decide if the affirmative or sceptic case was more likely. Finally, findings will be synthesised and used to draw conclusions about the effectiveness of MBT.

The HSCED lends itself to theory-building, as it gathers in-depth data from individuals and facilitates comparison within and between cases. Further, participants' contribution to their own 'rich case record' through change interviews recognises people as taking an active role in their own healing.

Read the detailed description

Study Design The study will involve single-centre convenience-sampling recruitment from a Later Life MBT Group run within Older Adult Community Mental Health Teams (CMHT) within Derbyshire Healthcare NHS Foundation Trust. The MBT intervention groups have been established for approximately 12 months and constitute an existing referral pathway within the Older Adult CMHT service. Given this, the study takes an observational design, as although participants receive a therapeutic intervention (MBT) the investigators will not assign a specific intervention to participants, rather they will recruit participants from an already established MBT group. The MBT intervention that participants will be receiving is therefore 'treatment as usual'.

The study will use a Hermeneutic Single-Case Efficacy Design (HSCED), an interpretative framework for evaluating causality between processes and outcomes in psychotherapeutic interventions (Elliott, 2001; Elliott, 2002). Based on several of Wall et al.'s (2017) HSCED adaptations, the study will recruit four to six participants (depending on drop-out rate), informants (people who know the participants), and four clinicians delivering the MBT intervention. This will allow for case-wise comparison and provide greater evidence for considering efficacy theory. Data collected will be both quantitative (questionnaires) and qualitative (free-form questionnaires, therapy documents and interviews).

Affirmative and sceptic cases will be developed and reviewed by the research team to ensure a fair presentation of the data. In addition, the HSCED design limits bias by the inclusion of the adjudicational panel, comprising judges who are independent of the research team. One judge will be an expert in MBT, one an expert in another therapeutic modality, and the final judge will be a service user who identifies as an older adult with attachment difficulties, offering the perspective of someone who might be eligible for the MBT intervention. For each participant, each expert will decide if the affirmative or sceptic case was more likely. Finally, findings will then be synthesised and used to draw conclusions about the effectiveness of MBT.

Being tested
Mentalization-Based Therapy
Keywords
mentalisation, mentalization, later life, older adults, attachment trauma, borderline personality disorder, attachment, bpd, mbt, mentalisation-based therapy, mentalization-based therapy
Medical subject headings
Borderline Personality Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mentalization-Based TherapyOther

    Also called MBT, Mentalisation-Based Therapy

    Group MBT that takes place as part of treatment as usual within Derbyshire Healthcare NHS Foundation Trust's Older Adult Community Mental Health Team's service.

Study groups in NCT07065071
Study groupRoleWhat they receive
Older adultsPeople aged 60+ who are eligible for Derbyshire Healthcare NHS Foundation Trust's Later Life MBT group
Receives: Other: Mentalization-Based Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Generalized Anxiety Disorder 7-item questionnaire (GAD-7)

    The GAD-7 is a self-report measure of 7 questions pertaining to frequency of symptoms of anxiety experienced over the past 2 weeks. Responses are given on a Likert scale ranging from 0-3, where 0 = 'not at all' and 3 = 'nearly every day', with higher scores indicating greater severity of symptoms of anxiety. Administered to participants.

    Measured: Administered at baseline, the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this.

  2. Personal Health Questionnaire, 9-item (PHQ-9)

    The PHQ-9 is a self-report measure of 9 questions pertaining to frequency of symptoms of depression experienced over the past 2 weeks. Responses are given on a Likert scale ranging from 0-3, where 0 = 'not at all' and 3 = 'nearly every day', with higher scores indicating greater severity of symptoms of depression. Administered to participants.

    Measured: Administered at baseline, the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this.

  3. Recovering Quality of Life 10 (ReQoL-10)

    The ReQoL-10 is a self-report measure of 10 questions pertaining to the respondent's frequency of thoughts, feelings and activities relevant to quality of life over the last week. Responses are given on a Likert scale ranging from 0-4, where 0 = 'none of the time' and 4 = 'most or all of the time', with higher scale scores indicating higher quality of life. Administered to participants.

    Measured: Administered at baseline, the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this. Also administered weekly at the start of MBT sessions for the duration of the MBT intervention (6 months and 7 weeks).

  4. Certainty About Mental States Questionnaire (CAMSQ)

    The CAMSQ is a self-report measure of 20 questions exploring respondent's interpretations of the thoughts, feelings and behaviours of themselves and others. Responses are given on a Likert scale ranging from 0-6, where 0 = 'never' and 6 = 'always'. For scoring, items are divided into two subscales, Certainty about Self and Certainty about Others. High scores on Self-Certainty and middling scores on Other-Certainty are considered to reflect adaptive mentalizing. Administered to participants.

    Measured: Administered at baseline, the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this. Also administered weekly at the end of MBT sessions for the duration of the MBT intervention (6 months and 7 weeks).

  5. Brief Reflective Functioning Interview (BRFI; adapted)

    The Brief Reflective Functioning Interview (BRFI) is a short semi-standardized interview that is based on the Adult Attachment Interview (AAI), in which participants are asked to reflect on any relationship with someone they have known for a long time. This adapted version is based on Rudden (2010). There are 9 questions, including 'Can you tell me about a specific memory with that person from when you were younger that shows something about your relationship?' and 'Why did you choose to speak about this person?'. Administered to participants. Responses will be coded using the Reflective Functioning Scale to ascertain levels of mentalizing.

    Measured: Administered at baseline, the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this.

  6. Helpful Aspects of Therapy Questionnaire (HAT)

    The HAT is a qualitative self-report measure of 7 questions exploring helpful and hindering events during therapy sessions. Respondents are asked to briefly write their answers to questions such as 'Of the events which occurred during this session, which one do you feel was the most helpful or important for you personally?', 'Did anything happen during the session that might have been hindering?', 'About where in the session did this event occur?' and 'How long did this event last?'. Respondents are also invited to quantitatively rate the helpfulness of the event using a Likert scale ranging from 1-9, where 1 = 'extremely hindering' and 9 = 'extremely helpful'. Administered to participants and clinicians.

    Measured: Administered weekly at the end of MBT sessions for the duration of the MBT intervention (6 months and 7 weeks).

  7. Mentalization-Based Therapy (MBT) Adherence & Competence Scale

    The MBT Adherence \& Competence Scale is a self-report measure of 18 items pertaining to fidelity to the MBT model. Ratings are given on a Likert scale ranging from 0-7, where 0 = 'not at all' and 7= 'extensively', where higher scores indicate higher fidelity to MBT. The scale accounts for Frequency, Extensiveness and Quality of interventions, including whether an intervention is absent when it should have been used. Completed by clinicians.

    Measured: Administered weekly at the end of MBT sessions for the duration of the MBT intervention (6 months and 7 weeks).

  8. Change Interview Schedule

    The Change Interview Schedule is a semi-structured interview schedule exploring change, adapted from Elliot (1996) and Elliot (1999). There are 11 questions including 'What has the MBT group been like for you (so far)?' and 'In general, what do you attribute these various changes to? In other words, what do you think might have brought them about? Both outside and inside of being in the group.' Administered to participants, informants and clinicians.

    Measured: Administered at the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this.

  9. MBT Documents

    Any documents or paperwork completed or created by participants during MBT will be analysed for change over time and/or themes related to mentalization.

    Measured: Administered at the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2025
  2. Study start1 Apr 2025
  3. Primary completion22 Jan 2026
  4. Study completion22 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
3 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07065071
Sponsor's protocol ID
24072
Other IDs
349077
Status last verified
Feb 2026
First submitted
3 Mar 2025
Last updated
5 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Mentalisation and Mentalization, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Generalized Anxiety Disorder 7-item questionnaire (GAD-7) (time frame: Administered at baseline, the end of the introduction to MBT phase (roughly 7 weeks), and 6 months subsequent to this.). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in